Protembis Overview

  • Founded
  • 2013

Founded
  • Status
  • Private

  • Employees
  • 10

Employees
  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 13

Protembis General Information

Description

Operator of a medical device company intended to develop a minimally invasive and catheter-based filter device. The company's device minimizes the risk of brain injury as the filter blocks embolic debris from entering the blood vessels leading to the brain during cardiovascular interventions such as transcatheter aortic valve replacement procedures, enabling patients to enhance their quality of life and reduce overall healthcare costs associated with brain injury during surgical procedures.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Primary Office
  • Pauwelsstraße 17
  • 52074 Aachen
  • Germany
+49 0241 00000000

Protembis Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Protembis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 08-Apr-2022 0000 Completed Clinical Trials - General
4. Later Stage VC (Series A) 26-Oct-2018 0000 0000 000.00 Completed Clinical Trials - General
3. Accelerator/Incubator 25-Jul-2017 Completed Pre-Clinical Trials
2. Seed Round 28-Jul-2015 Completed Startup
1. Grant 24-Apr-2015 Completed Startup
To view Protembis’s complete valuation and funding history, request access »

Protembis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a medical device company intended to develop a minimally invasive and catheter-based filter device. The comp
Surgical Devices
Aachen, Germany
10 As of 2022
0000
0000000000 0 0000

000000

in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occa
00000000 0000000
Grand Rapids, MI
0000
0000000000 0 0000

000000

enderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupi
00000000 0000000
Tampa, FL
000.00
000000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Protembis Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Innovative Cardiovascular Solutions Venture Capital-Backed Grand Rapids, MI 0000 0000000000 0 0000
00000000 00000 Private Equity-Backed Tampa, FL 000.00 000000000000 000.00
00000 0000000 Venture Capital-Backed Prairie Village, KS 00 000.00 00000000000 000.00
00000000 Venture Capital-Backed Santa Cruz, CA 0 0000 00000000000 0000
00000 0000000 Formerly VC-backed Irvine, CA 000 00000 00000000 00000
You’re viewing 5 of 10 competitors. Get the full list »

Protembis Patents

Protembis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-102020110715-A1 Embolic protection device for feeding into an aortic arch Pending 28-Jun-2019 000000000
EP-3989873-A1 Embolism protection device for introducing into an aortic arch Pending 28-Jun-2019 000000000
CA-3144297-A1 Embolism protection device for introducing into an aortic arch Pending 28-Jun-2019 000000000
AU-2020301584-A1 Embolism protection device for introducing into an aortic arch Pending 28-Jun-2019 000000000
AU-2020307059-A1 Embolism protection device for introducing into an aortic arch Pending 28-Jun-2019 A61F2/013
To view Protembis’s complete patent history, request access »

Protembis Executive Team (3)

Name Title Board Seat Contact Info
Conrad Rasmus Co-Founder, Co-Chief Executive Officer, Managing Director & Board Member
Karl von Mangoldt Co-Founder, Co-Chief Executive Officer, Managing Director & Board Member
Oliver Schumacher Co-Founder & Chief Technology Officer
To view Protembis’s complete executive team members history, request access »

Protembis Board Members (1)

Name Representing Role Since
Sebastian Pünzeler Ph.D Coparion Board Member 000 0000
To view Protembis’s complete board members history, request access »

Protembis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Protembis Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Abiomed Corporation Minority 000 0000 000000 0
Andreas Bremke Angel (individual) Minority 000 0000 000000 0
BPO Capital (Hamburg) Venture Capital Minority 000 0000 000000 0
Coparion Venture Capital Minority 000 0000 000000 0
Hamba Investments Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »